Cnty-101
R/R CD19-Positive B-Cell Malignancies
Century Therapeutics, Inc.Phase 1
—
Rating in progress
Cnty-101 in R/R CD19-Positive B-Cell Malignancies is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active